Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

32,500

Employees32,500

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

32,500

Employees32,500

BMY Key Statistics

Market cap

120.05B

Market cap120.05B

Price-Earnings ratio

17.04

Price-Earnings ratio17.04

Dividend yield

4.22%

Dividend yield4.22%

Average volume

12.92M

Average volume12.92M

High today

$60.06

High today$60.06

Low today

$58.75

Low today$58.75

Open price

$59.67

Open price$59.67

Volume

2.83M

Volume2.83M

52 Week high

$62.89

52 Week high$62.89

52 Week low

$42.52

52 Week low$42.52

Stock Snapshot

The current Bristol-Myers Squibb(BMY) stock price is $58.95, with a market capitalization of 120.05B. The stock trades at a price-to-earnings (P/E) ratio of 17.04 and offers a dividend yield of 4.2%.

During the trading session on 2026-03-13, Bristol-Myers Squibb(BMY) shares reached a daily high of $60.06 and a low of $58.75. At a current price of $58.95, the stock is +0.3% higher than the low and still -1.8% under the high.

Trading volume for Bristol-Myers Squibb(BMY) stock has reached 2.83M, versus its average volume of 12.92M.

Over the past 52 weeks, Bristol-Myers Squibb(BMY) stock has traded between a high of $62.89 and a low of $42.52.

BMY News

Simply Wall St 20h

A Look At Bristol Myers Squibb Valuation After Recent Share Price Volatility

Advertisement Why Bristol-Myers Squibb (BMY) is on investors’ radar today Bristol-Myers Squibb (BMY) has drawn attention after a recent move in its share pric...

Nasdaq 1d

Interesting BMY Put And Call Options For May 1st

Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options become available today, for the May 1st expiration. At Stock Options Channel , our YieldBoos...

TipRanks 4d

Balanced Outlook on BMY: Positive Mezigdomide Phase III Data Support CELMoD Platform, but Long-Term Execution Risks Warrant Hold Rating

William Blair analyst Matt Phipps has maintained their neutral stance on BMY stock, giving a Hold rating on March 6. Matt Phipps has given his Hold rating due...

Analyst ratings

59%

of 32 ratings

Buy

37.5%

Hold

59.4%

Sell

3.1%

More BMY News

TipRanks 7d

Bristol-Myers Squibb Tracks Real-World Impact of KarXT in Schizophrenia

Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. The Bristol-Myers Squibb study “Effectiveness and Adverse-effect Switch...

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.